Table 3 Demographic data and medication in the LDHF and HDHF groups
LDHF (n = 22) | HDHF (n = 18) | sign. | ||
|---|---|---|---|---|
Age (years) | 59 (38-64) | 60 (39-78) | n.s. | |
Weight (kg) | 86 (70 - 115) | 82 (63-91) | n.s. | |
Height (cm) | 180 (160 - 190) | 172 (160-185) | n.s. | |
Male/Female | 21/1 | 14/4 | n.s. | |
LVEF [%] | 60 (20 - 65) | 45 (30 - 60) | n.s. | |
Previous MI | [yes/no] | 18/4 | 10/8 | n.s. |
Previous CABG | [yes/no] | 10/22 | 9/18 | n.s |
Previous PCI | [yes/no] | 11/22 | 10/18 | n.s. |
Pos. ischemia testing | [yes/no] | 0/22 | 5/13 | p = 0.013 |
Duration of IHD | [months] | 1 (1-50) | 2 (1 - 120) | n.s. |
Betablocker | [yes/no] | 22/0 | 18/0 | n.s. |
ACE-inhibitor/ARB | [yes/no] | 17/5 | 17/1 | n.s. |
Diuretics | [yes/no] | 5/17 | 9/9 | (p = 0.08) |
Aldosterone-Blocker | [yes/no] | 0/22 | 1/17 | n.s. |
Digitalis | [yes/no] | 2/20 | 7/11 | p = 0.025 |